US2005158716A1PendingUtilityA1

Nucleic acid detection kits

Assignee: THIRD WAVE TECH INCPriority: Dec 7, 1992Filed: Apr 8, 2003Published: Jul 21, 2005
Est. expiryDec 7, 2012(expired)· nominal 20-yr term from priority
C12Q 1/6886C12N 9/1252C12N 15/113C12Q 1/682C12Q 1/689C12N 15/10C07K 14/82C12Q 1/683C12Q 1/6823C07H 21/00C07K 14/4746
63
PatentIndex Score
0
Cited by
0
References
0
Claims

Abstract

The present invention relates to means for cleaving a nucleic acid cleavage structure in a site-specific manner. Enzymes, including 5′ nucleases and 3′ exonucleases, are used to detect and identify nucleic acids derived from microorganisms. Methods are provided which allow for the detection and identification of bacterial and viral pathogens in a sample.

Claims

exact text as granted — not AI-modified
1 . A method for identifying strains of microorganisms comprising: 
 a) providing 
 i) a cleavage means; and  
 ii) a nucleic acid substrate containing sequences derived from one or more microorganism;  
   b) treating said nucleic acid substrate under conditions such that said substrate forms one or more cleavage structures; and    c) reacting said cleavage means with said cleavage structures so that one or more cleavage products are produced.    
     
     
         2 . The method of  claim 1 , wherein said cleavage means is an enzyme.  
     
     
         3 . The method of  claim 2 , wherein said enzyme is a nuclease.  
     
     
         4 . The method of  claim 3 , wherein said nuclease is selected from the group consisting of Cleavase™ BN ,  Thermus aquaticus  DNA polymerase,  Thermus thermophilus  DNA polymerase,  Escherichia coli  Exo III, and the  Saccharomyces cerevisiae  Rad1/Rad10 complex.  
     
     
         5 . The method of  claim 1 , wherein said nucleic acid substrate comprises a nucleotide analog.  
     
     
         6 . The method of  claim 5 , wherein said nucleotide analog is selected from the group comprising 7-deaza-dATP, 7-deaza-dGTP and dUTP.  
     
     
         7 . The method of  claim 1 , wherein said nucleic acid of step (a) is substantially single-stranded.  
     
     
         8 . The method of  claim 1 , wherein said nucleic acid is RNA.  
     
     
         9 . The method of  claim 1 , wherein said nucleic acid is DNA.  
     
     
         10 . The method of  claim 1 , wherein said nucleic acid of step (a) is double stranded.  
     
     
         11 . The method of  claim 10 , wherein said treating of step (b) comprises: 
 i) rendering said double-stranded nucleic acid substantially single-stranded; and    ii) exposing said single-stranded nucleic acid to conditions such that said single-stranded nucleic acid has secondary structure.    
     
     
         12 . The method of  claim 11 , wherein said double-stranded nucleic acid is rendered substantially single-stranded by increased temperature.  
     
     
         13 . The method of  claim 1 , further comprising the step of detecting said one or more cleavage products.  
     
     
         14 . The method of  claim 1  wherein said microorganism comprises bacteria.  
     
     
         15 . The method of  claim 14  wherein said bacteria are selected from the group comprising members of the genera  Campylobacter, Escherichia, Mycobacterium, Salmonella, Shigella  and  Staphylococcus.    
     
     
         16 . The method of  claim 15  wherein said members of the genus  Mycobacterium  comprise strains of multi-drug resistant  Mycobacterium tuberculosis.    
     
     
         17 . The method of  claim 1  wherein said microorganism comprises virus.  
     
     
         18 . The method of  claim 17  wherein said virus is selected from the group comprising hepatitis C virus and simian immunodeficiency virus.  
     
     
         19 . A method for detecting and identifying strains of microorganisms, comprising: 
 a) extracting nucleic acid from a sample suspected of containing one or more microorganisms; and    b) contacting said extracted nucleic acid with a cleavage means under conditions such that said extracted nucleic acid forms one or more secondary structures, and said cleavage means cleaves said secondary structures to produce one or more cleavage products.    
     
     
         20 . The method of  claim 19 , further comprising the step of separating said cleavage products.  
     
     
         21 . The method of  claim 19 , further comprising the step of detecting said cleavage products.  
     
     
         22 . The method of  claim 21 , further comprising comparing said detected cleavage products generated from cleavage of said extracted nucleic acid isolated from said sample with separated cleavage products generated by cleavage of nucleic acids derived from one or more reference microorganisms.  
     
     
         23 . The method of  claim 19  further comprising the step of isolating a polymorphic locus from said extracted nucleic acid after the extraction of step a), to generate a nucleic acid substrate wherein said substrate is contacted with the cleavage means of step b.  
     
     
         24 . The method of  claim 23  wherein said isolation of a polymorphic locus is accomplished by polymerase chain reaction amplification.  
     
     
         25 . The method of  claim 24 , wherein said polymerase chain reaction is conducted in the presence of a nucleotide analog.  
     
     
         26 . The method of  claim 25 , wherein said nucleotide analog is selected from the group comprising 7-deaza-dATP, 7-deaza-dGTP and dUTP.  
     
     
         27 . The method of  claim 24  wherein said polymerase chain reaction amplification employs oligonucleotide primers matching or complementary to consensus gene sequences derived from said polymorphic locus  
     
     
         28 . The method of  claim 23  wherein said polymorphic locus comprises a ribosomal RNA gene.  
     
     
         29 . The method of  claim 28 , wherein said ribosomal RNA gene is a 16S ribosomal RNA gene.  
     
     
         30 . The method of  claim 19 , wherein said cleavage means is an enzyme.  
     
     
         31 . The method of  claim 30 , wherein said enzyme is a nuclease.  
     
     
         32 . The method of  claim 31 , wherein said nuclease is selected from the group consisting of Cleavase™ BN,  Thermus aquaticus  DNA polymerase,  Thermus thermophilus  DNA polymerase,  Escherichia coli  Exo III, and the  Saccharomyces cerevisiae  Rad1/Rad10 complex.  
     
     
         33 . The method of  claim 19 , wherein said nucleic acid of step (a) is substantially single-stranded.  
     
     
         34 . The method of  claim 19 , wherein said nucleic acid is RNA.  
     
     
         35 . The method of  claim 19 , wherein said nucleic acid is DNA.  
     
     
         36 . The method of  claim 19 , wherein said nucleic acid of step (a) is double stranded.  
     
     
         37 . The method of  claim 36 , wherein said treating of step (b) comprises: 
 i) rendering said double-stranded nucleic acid substantially single-stranded; and    ii) exposing said single-stranded nucleic acid to conditions such that said single-stranded nucleic acid has secondary structure.    
     
     
         38 . The method of  claim 37 , wherein said double-stranded nucleic acid is rendered substantially single-stranded by increased temperature.  
     
     
         39 . The method of  claim 19  wherein said microorganism comprises bacteria.  
     
     
         40 . The method of  claim 39  wherein said bacteria are selected from the group comprising members of the genera  Campylobacter, Escherichia, Mycobacterium, Salmonella, Shigella  and  Staphylococcus.    
     
     
         41 . The method of  claim 40  wherein said members of the genus  Mycobacterium  comprise strains of multi-drug resistant  Mycobacterium tuberculosis.    
     
     
         42 . The method of  claim 19  wherein said microorganism comprises virus.  
     
     
         43 . The method of  claim 42  wherein said virus is selected from the group comprising hepatitis C virus and simian immunodeficiency virus.  
     
     
         44 . A method for treating nucleic acid comprising an oligonucleotide containing microbial gene sequences, comprising: 
 a) providing 
 i) a cleavage means in a solution containing manganese; and  
 ii) nucleic acid substrate containing microbial gene sequences;  
   b) treating said nucleic acid substrate with increased temperature such that said substrate is substantially single-stranded;    c) reducing said temperature under conditions such that said single-stranded substrate forms one or more cleavage structures;    d) reacting said cleavage means with said cleavage structures so that one or more cleavage products are produced; and    e) detecting said one or more cleavage products.

Join the waitlist — get patent alerts

Track US2005158716A1 — get alerts on status changes and closely related new filings.

We store only your email — no account needed. See our privacy policy.